Antituberculous treatment of erythema induratum Bazin.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D007871:Leg Ulcer / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010118:Oxytetracycline / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use*; D014374:Tuberculin Test; D014376:Tuberculosis / Q000150:complications; D014382:Tuberculosis, Cutaneous / Q000150:complications / Q000188:drug therapy*; D014388:Tuberculosis, Lymph Node / Q000150:complications; D014397:Tuberculosis, Pulmonary / Q000150:complications
D000636:Aminosalicylic Acids; D009824:Ointments; D011736:Pyridoxine; D007538:Isoniazid; D010118:Oxytetracycline; D013307:Streptomycin